Do you want to read an article? Please log in or register.
Ophthalmic Disease Burden in Adults with Autism Spectrum Disorder
Further Publications
RECOMMENDED
Related content
Macular DiseasesFurther Publications
Prevalence, Risk Determinants, and Burden of Undiagnosed Age-Related Eye Diseases Among Older Asian Adults
JAMA Ophthalmol
Yee H, Wong CMJ, Gupta P, Thakur S, Fenwick E, Lamoureux EL, Man REK
doi: 10.1001/jamaophthalmol.2025.4623
Further Publications
Ophthalmic manifestations of Danon disease: A systematic review
Am J Ophthalmol
Emfietzoglou M, Sakuno G, Awh C, Hoyek S, Bantounou MA, Baroutis KG, Chatziralli I, Papakonstantinou D, Theodossiadis P, Charonis A, Patel NA, Vavvas DG
doi: 10.1016/j.ajo.2026.03.026
Cornea and Corneal Diseases
Cumulative Atopic Disease Burden and Keratoconus: Cross-Sectional and Longitudinal Associations in the All of Us Research Program
Am J Ophthalmol
Butt FR (c), Dhivagaran T (c), Miller T (c), Muayad J, Al-Burak SA (c), Abid F, Nassrallah W, Tao B, Ahmed Y, Chan CC
doi: 10.1016/j.ajo.2026.09.001
Retinal DiseasesFurther Publications
Adult-onset Coats disease: A systematic review and meta-analysis of imaging biomarkers and targeted therapies
Acta Ophthalmol
Francisco C, Silva N, Boon CJF
doi: 10.1111/aos.70149
Blindness and Vision Impairment
Persistent socioeconomic disparities and delayed onset in blindness due to neonatal disorders: global burden and future projections
Br J Ophthalmol
Li S, Shen W, Shi M, Fang Y, Liu L, Shao R, Zhao C, Wu L
doi: 10.1136/bjo-2025-327558
Retinal Diseases
Optic disc flavoprotein fluorescence imaging as a novel method to quantify disease burden in optic disc drusen
Am J Ophthalmol
Pujari RR, Yu M, Zhang J, Almeda L, Pugazhendhi S, Zhu P, Rich C, Moss HE, Beres S, Liao YJ
doi: 10.1016/j.ajo.2025.11.018
Retinal Diseases
Intravitreal Therapy in Adults Aged ≤50 Years: Etiologic Spectrum, Treatment Patterns and Visual Outcomes in a Real-World Cohort
J Clin Med
Rodríguez-Fernández CA, Oliver-Gutierrez D, Arnaiz A, Pablos T, Segura-Duch G, Zapata MÁ
doi: 10.3390/jcm15124508
RECOMMENDED
Dry Eye Disease
Lifitegrast Ophthalmic Solution 5.0% (KH732) for Dry Eye Disease: A randomized, Multicenter, Double-Masked, vehicle-controlled Phase 3 Trial
★ 2
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
Ocul Surf
Lu Y, Jin X, Li X, Jie Y, Tao L, Ren S, Zhao S, Li Y, Xu G, Zhuang W, Li Y, Chen W, Cai S, Gu H, Zhang H, Li L, You Z, Li J, Zhao J, Chen Q, Huang T, Wu P, Wang T, Yao Y, Wang H, Li Z, Shu X, Wang R, Zhang M, Wen F, Fu Y, Pei C, Zhang W, Guan H, Zhao H, Yang J, Song L, He M, Lv X, Wu F, Gong L, Sun X
doi: 10.1016/j.jtos.2026.04.006
Dry Eye Disease
Acoltremon Ophthalmic Solution 0.003% for Signs and Symptoms of Dry Eye Disease: Results of Phase 3 Pivotal Studies COMET-2 and COMET-3
Ophthalmology
Pattar GR, Wirta D, Jerkins G, Paauw J, McLaurin EB, Liu A, Evans DG, Kenyon K, Cline N, Gupta PK, Meng I, Senchyna M, COMET-2 and COMET-3 study groups
doi: 10.1016/j.ophtha.2025.09.018